Guizhou Yibai Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Yibai Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Tianjin Chase Sun Pharmaceutical Company Limited
sales of 3.35 billion Chinese Renmimbi [US$489.58 million]
of which 50%
was Finished Medicine),
Shijiazhuang Yiling Pharmaceutical Co Ltd
(3.18 billion Chinese Renmimbi [US$465.62 million]
of which 100%
was Medicine), and
Jinling Pharmaceutical Company Limited
(3.22 billion Chinese Renmimbi [US$470.67 million]
of which 72%
was Medicine Manufacture).
During the year ended December of 2015, sales at
Guizhou Yibai Pharmaceutical Co., Ltd. were 3.30 billion Chinese Renmimbi (US$482.89 million).
increase of 4.6%
versus 2014, when the company's sales were 3.16 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guizhou Yibai Pharmaceutical Co., Ltd.
(and since 2010, sales have increased a total of 125%).
Sales of Medicine saw an increase
that was more than double the company's growth rate: sales were up
62,547.2% in 2015, from
748,717.95 Chinese Renmimbi to 469.05 million Chinese Renmimbi.
Not all segments of Guizhou Yibai Pharmaceutical Co., Ltd. experienced an increase in sales in 2015:
sales of Medical Service fell 32.6% to 163.23 million Chinese Renmimbi.